Patient Care Costs in Cancer Clinical Trials

Publication
Article
OncologyONCOLOGY Vol 15 No 6
Volume 15
Issue 6

Rep. Pryce is also cochair of the House Cancer Working Group. In March, she introduced the Access to Cancer Clinical Trials Act (H.R. 967), which would require health insurers to pay for the routine costs incurred by patients in

Rep. Pryce is also cochair of the House Cancer Working Group. InMarch, she introduced the Access to Cancer Clinical Trials Act(H.R. 967), which would require health insurers to pay for the routine costsincurred by patients in cancer clinical trials. This would be a further step infederal policy beyond the Clinton administration’s national coverage decisionthat went into effect in September 2000. The Pryce bill calls for coverage ofall participants in cancer clinical trials, regardless of age, including thoseconducted by nonfederal research entities—a category of trials not included inthe Clinton policy.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.
2 experts in this video